[HTML][HTML] Outcomes after liver transplantation in accordance with ABO compatibility: a systematic review and meta-analysis
EC Lee, SH Kim, SJ Park - World journal of gastroenterology, 2017 - ncbi.nlm.nih.gov
AIM To evaluate the differences in outcomes between ABO-incompatible (ABO-I) liver
transplantation (LT) and ABO-compatible (ABO-C) LT. METHODS A systematic review and …
transplantation (LT) and ABO-compatible (ABO-C) LT. METHODS A systematic review and …
[HTML][HTML] Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan
T Hori, T Kaido, F Oike, Y Ogura, K Ogawa… - World journal of …, 2011 - ncbi.nlm.nih.gov
AIM: To investigate thrombotic microangiopathy (TMA) in liver transplantion, because TMA is
an infrequent but life-threatening complication in the transplantation field. METHODS: A total …
an infrequent but life-threatening complication in the transplantation field. METHODS: A total …
Management of cytomegalovirus infection after living donor liver transplantation.
K Yamanouchi, S Eguchi, M Takatsuki… - Hepato …, 2012 - europepmc.org
Results CMV antigenemia was demonstrated in 31 (43.1%) patients and 9 patients (12.5%)
manifested fever. Twelve patients were treated with intravenous ganciclovir (GCV) injection …
manifested fever. Twelve patients were treated with intravenous ganciclovir (GCV) injection …
[PDF][PDF] Contrast patterns of Cytomegalovirus and Epstein-Barr virus infection in pediatric living-donor liver transplant recipients
H Nafady-Hego, H Elgendy, S Uemoto - Exp Clin Transplant, 2015 - academia.edu
Abstract Objectives: Cytomegalovirus and Epstein-Barr virus remain leading causes of
morbidity and mortality in the living-donor liver transplant population, particularly in pediatric …
morbidity and mortality in the living-donor liver transplant population, particularly in pediatric …
[PDF][PDF] Who is at risk for developing cytomegalovirus (CMV) infection following liver transplantation?
JD Perkins - Liver Transplantation, 2007 - Wiley Online Library
Background Experimental data suggest that cytomegalovirus (CMV) initiates innate
immunity through the activation of Toll‐like receptor 2 (TLR2). To assess the clinical …
immunity through the activation of Toll‐like receptor 2 (TLR2). To assess the clinical …
[PDF][PDF] NAOSITE: Nagasaki University's Academic Output SITE
A Nanashima, Y Sumida, M Oikawa… - Journal of …, 2009 - researchgate.net
NAOSITE: Nagasaki University's Academic Output SITE Page 1 This document is downloaded at:
2019-03-19T02:59:04Z Title Closed complex of the D-3-hydroxybutyrate dehydrogenase induced …
2019-03-19T02:59:04Z Title Closed complex of the D-3-hydroxybutyrate dehydrogenase induced …
国立成育医療センターにおける肝移植成績
笠原群生， 福田晃也， 佐藤衆一， 重田孝信… - 日本小児外科学会 …, 2008 - jstage.jst.go.jp
[目的] 肝移植プログラム開始から 2 年が経過した国立成育医療センターにおける肝移植医療の
成績を報告する.[対象と方法] 国立成育医療センターにおいて 2005 年 11 月から 2008 年 2 …
成績を報告する.[対象と方法] 国立成育医療センターにおいて 2005 年 11 月から 2008 年 2 …